INTRODUCTION
for many years (Farquhar and Palade, 1981; Mellman and Simons, 1992; Rothman and Orci, 1992) . This is 1400 Jackson St., Denver, CO 80206. tened cisternae enriched in glycoprotein and glyco-lipid processing enzymes (Beams and Kessel, 1968; Rambourg and Clermont, 1990) . Specialized sorting and transport machinery enable the Golgi to filter selected membrane and protein components from secretory bulk flow derived from the endoplasmic reticulum (ER) (Pryer et al., 1992; Rothman, 1994) . Because many of the components of this machinery must be retrieved back to the ER for continued use, significant exchange of membrane occurs between the Golgi complex and the ER (Pelham, 1991) . Despite its distinctive morphology, localization, and function within cells, the Golgi complex is capable of rapid disassembly and reassembly during mitosis Warren, 1993) , as well as under pharmacologically induced conditions (e.g. brefeldin A [BFAI, okadaic acid, and ilimaquinone (IQ)) (Lippincott-Schwartz et al., 1990; Lucocq et al., 1991; Takizawa et al., 1993) and reversibly redistributes to numerous peripheral sites in response to microtubule depolymerization (Pavelka and Ellinger, 1983; Thyberg and Moskalewski, 1985; Turner and Tartakoff, 1989) . How Golgi fragmentation and dispersal during these processes is accomplished is far from being understood. In this study we analyze the process of Golgi dispersal during microtubule depolymerization with the goal of understanding how it occurs and why. It is well known that microtubules underlie the centrosomal positioning of the Golgi complex within nonpolarized cells (Wehland et al., 1983; Thyberg and Moskalewski, 1985) and that Golgi elements actively translocate along microtubules to reach this position (Ho et al., 1989) . It is also recognized that microtubules play roles in facilitating membrane traffic to and from the Golgi complex (Saraste and Svensson, 1991; Mizuno and Singer, 1994; Lippincott-Schwartz et al., 1995) . Secretory products leaving the Golgi complex, for example, have been shown to use microtubules to localize to specific sites on the plasma membrane . Moreover, Golgi localization near the microtubuleorganizing center likely facilitates communication between secretory and endocytic pathways (Farquhar, 1991; Cole and Lippincott-Schwartz, 1995) and appears to centralize early secretory membrane flow, which originates from numerous ER transitional element sites scattered throughout the elaborate network of ER that fills the cytoplasm (Plutner et al., 1992; Saraste and Kuismanen, 1992) .
Despite roles for microtubules in the localization of Golgi elements, microtubule disruption does not always interfere with membrane flow through the secretory pathway Van De Moortele et al., 1993) . It does, however, have dramatic effects on Golgi morphology, with hundreds of functional Golgi islands now appearing throughout the cytoplasm (Pavelka and Ellinger, 1983; Thyberg and Moskalewski, 1985; Turner and Tartakoff, 1989) . How this dramatic redistribution of Golgi membrane occurs without fundamentally disrupting secretory flow from the ER is unknown. A widely acknowledged mechanism for Golgi dispersal during microtubule disruption is that it results from random diffusion of Golgi elements no longer tethered together by microtubules . Recent biophysical studies on the properties of the cytoplasm, however, lead to the question of how random dispersal of membrane structures the size of Golgi fragments could occur throughout a cytoplasm consisting of a dense, gel-like cytoskeletal matrix (Luby-Phelps, 1994; Penman, 1995) . Moreover, Golgi dispersal has been shown to be an energy-dependent and temperature-sensitive process (Turner and Tartakoff, 1989) , indicating that microtubule depolymerization alone is not sufficient for Golgi dispersal. These requirements indicate more is at work during Golgi dispersal than simple diffusion.
In this paper we explore potential mechanisms of Golgi dispersal during microtubule depolymerization by examining the characteristics of the dispersal process, including where Golgi membrane redistributes within the cytoplasm and the rate at which different Golgi membrane components redistribute to these sites. We also ask whether Golgi dispersal reflects properties of normal membrane trafficking within the cell, and examine the effects of microtubule depolymerization on membrane trafficking pathways leading to and from the Golgi. Finally, we consider whether Golgi dispersal serves any role in reestablishing secretory traffic after microtubule disruption. Our results demonstrate that upon microtubule disruption Golgi membrane components gradually redistribute to peripheral sites of membrane export from the ER where functional Golgi stacks are regenerated. Before this redistribution a significant block in secretory traffic and Golgi processing occurs, which is overcome only when Golgi stacks are rebuilt in the cell periphery. We propose that a slow but constitutive flux of Golgi enzymes through pathways connecting the ER and Golgi underlies this phenomenon, with Golgi enzymes accumulating at peripheral ER exit sites as a consequence of the inability of membranes at these sites to cluster into the centrosomal region in the absence of microtubules. Reassembly of small Golgi stacks at these peripheral sites would allow secretory flow from the ER into the Golgi to continue and would explain the dispersal of Golgi elements observed during microtubule depolymerization.
MATERIALS AND METHODS

Materials and Cell Culture
Nocodazole was purchased from Sigma Chemical (St. Louis, MO) and was used at concentrations between 1 and 5 ,Lg/ml. When added to cells at 4°C, subsequent incubation at 37'C resulted in the Effects of Microtubule Disruption on Golgi depolymerization of all microtubules (detected by immunofluorescence) within 5 min of warming. BFA was purchased from Epicentre Technology (Madison, WI) and was used at 1-5 ,ug/ml. N-ethylmaleimide (NEM), monensin, 2-deoxy glucose (DOG), and cytochalasin D were all purchased from Sigma Chemical. Endoglycosidase H (endo H) was purchased from New England Biolabs (Beverly, MA). AcrylAide cross-linker and GelBond PAG film were purchased from FMC Bioproducts and used as described by the manufacturer's instructions (Rockland, ME).
NRK, HeLa, and Ml fibroblasts were grown in DMEM supplemented with 10% fetal calf serum, 2 mM glutamine, and 150 jig/ml penicillin or 2.5 ,ug/ml gentamicin at 37°C in 5% CO2. Human versus rodent cell types were used in different experiments because of differences in species specificity of antibodies to the Golgi and pre-Golgi markers under study.
Antibodies
The 
VSV Infection
Infections with ts045 VSV were performed according to a modification of the method of Bergmann (1989 The image processing for Figure 2 began by subtracting the appropriate background image from each raw image to correct for uneven illumination. Image masks were then generated, correlating to the Golgi regions, as follows. It was not possible to select the Golgi regions by simple intensity thresholding of the images because thresholding values (i.e., pixel intensity ranges) to distinguish between adjacent bright fragments would not detect dimmer fragments (and vice versa). We circumvented this problem by subtracting from each image, a copy of itself that was blurred by convolving the image with a 5 x 5 mean neighborhood filter twice, and then the resultant image was segmented by eye (in comparison with the original image) and a binary "mask" that had values of "1'" for the Golgi regions and "0" for all other regions of the image was created. These masks were then used for enumerating the Golgi fragmentation process with the cell boundaries defined by eye. The computer counted only fragments greater than 3 pixels in area; a pixel was measured to be approximately 0.219 gm in length. This image processing algorithm for distinguishing Golgi from non-Golgi regions was verified by comparing the computer-generated data with those of three separate and independent experimenters manually counting Golgi fragments from computer images and/or photographs.
The binary image masks were also used for application of a look-up table that roughly correlated with the concentration of the Golgi enzyme Galtf. Here the masks were multiplied with the background-subtracted images and the resultant images were then colored on a pixel by pixel basis as described in the caption of Figure  2 . Intensity measurement errors due to out of focal plane fluorescence were most pronounced in the thicker portions of cells (in the perinuclear regions). Our interest, however, was how intensity values between sets of Golgi fragments in the cell periphery (in thinner cell regions) changed over time. To minimize errors in this analysis, we selected large flat cells to sample and used an objective with a deep depth of field (to image as many fragments per cell as possible). When serial Z-section slices (step size = 0.26 ,um) of several cells were collected and inspected, we found that approximately 90% of the Golgi elements were detected by our approach. To verify that changes in fragment intensity at different times in nocodazole reflected changes in distribution of Galtf within the cell and not a loss or gain of total fluorescence signal, we compared total cellular fluorescence at these times. Using IPLab software a region of interest was drawn around each cell and the average fluorescence intensity per cell was measured for a minimum of 12 cells per time point after subtracting background fluorescence. The average intensity per cell in arbitrary fluorescence units (a.f.u.) fell within the ranges of 6 x 106 to 9 X 106 at all time points, with the average fluorescence at 1 h being 9 x 106 + 106 and at 10 h being 8.3 x 106 + 106 a.f.u. This indicates that the overall total fluorescence intensity changed very little during the course of the experiment.
Changes in area of Golgi fragments as a function of time in nocodazole were also examined using the binary image masks. Here, images were color coded based on their size (i.e., number of pixels per fragment). Our unpublished observations revealed that the area of peripheral fragments increased during the first 4 h of nocodazole treatment.
RESULTS
Fluorescence Imaging of Golgi Fragmentation Induced by Microtubule Disruption
To analyze Golgi dispersal during microtubule disruption we used digital fluorescence imaging techniques to follow the time course of this process. With such an approach we hoped to determine how quickly Golgi fragments are generated, the extent of fragmentation, and whether changes in concentration of Golgi enzymes within fragments occurs over time. Answers to these questions are crucial for evaluating different models of Golgi fragmentation and for providing a framework for investigating the responsible mechanisms.
Golgi dispersal was monitored in HeLa cells preincubated on ice (to depolymerize microtubules) and then warmed to 37°C in the presence of nocodazole. Under these conditions all microtubules detected with an anti-a tubulin antibody were depolymerized within 1 min of warmup (our unpublished observations). To follow the redistribution of Golgi membrane during nocodazole treatment, cells were fixed after progressive time intervals in the drug, permeabilized, and the Golgi enzyme marker Galtf was localized by indirect fluorescence microscopy. Digital images of representative cells were acquired using a fluorescence microscope system equipped with a cooled charge-coupled device. The number, size, relative fluorescence intensity, and distribution of Golgi fragments generated at different times after microtubule depolymerization were then analyzed. As described in MATERIAL AND METHODS, Golgi fragments were identified as punctate spots (from 4-40 pixels in size) that had fluorescence intensities above a minimal threshold that was easily distinguished by eye. Due to the flatness of these cells, greater than 90% of all Golgi fragments within cells could be observed in a single focal plane setting, with those fragments that were out of focus limited to the region above and below the nucleus.
As shown in Figure 1 , Golgi fragments became apparent within 15 min of nocodazole treatment with 20-60 fragments detected per cell compared with one to four Golgi elements identified in untreated cells. The number of fragments per cell quickly rose during the first 90 min of nocodazole treatment to approximately 200 fragments per cell. Thereafter, the number of fragments leveled off, with the average number of fragments per cell remaining constant at approximately 250 for up to 14 h of nocodazole treatment. Similar shaped curves were seen in multiple experiments with HeLa, Chinese hamster ovary, and NRK cells using species-specific antibodies to Golgi resident proteins; however, the time course of the redistribution varied with cell type (our unpublished observations). When cycloheximide was added at the time of nocodazole treatment, no change in the rate or extent of Golgi fragmentation was observed, indicating that new protein synthesis was not required for the observed effects.
To follow the overall distribution and intensity of Golgi fragments generated with time of treatment in nocodazole, fluorescent intensity measurements from the Galtf-enriched Golgi fragments were collected. The distribution of Golgi fragments and fragment in- Galtf-derived fluorescence reflected changes in distribution of this enzyme within the cell and not a loss or gain of total enzyme or fluorescence signal.
As shown in Figure 2 , in untreated cells (0 min) Golgi elements were restricted to a single juxtanuclear location near the centrosome and had high (yellow) and medium high (blue) intensity values. At 15 min of nocodazole treatment, Golgi elements in central sites were still of very high intensity (yellow and blue), but a number of very low (red) intensity fragments began to appear throughout the cytoplasm. Although many of these fragments were in the vicinity of the central bright Golgi elements, some were surprisingly far removed from this centrosomal location. Between 30 and 60 min of nocodazole treatment, the number of peripheral Golgi fragments grew significantly until it leveled off at approximately 250 fragments per cell (see Figure 1) . Strikingly, although the Golgi fragment number had leveled off by 90 to 120 min of nocodazole treatment, the intensity of individual fragments continued to change for up to 6 h. The originally bright central Golgi elements became dimmer with increasing times in nocodazole, while peripheral fragments became brighter. This indicated that Galtf continued to redistribute to peripheral fragments after the number of fragments had stopped increasing. After 6 h of 600 800 nocodazole treatment, both peripheral and central Golgi fragments exhibited the same medium (green)
,i fragments in no-intensity range. Addition of cycloheximide at the time d on ice for 10 min of nocodazole treatment did not alter these results. aed to 37'C in the Examination of the size of the peripheral fragments To test whether other Golgi membrane components redistributed at the same or different rates to peripheral sites, we compared nocodazole's effects on the distribution of Galtf with that of an itinerant Golgi marker, ERGIC-53 (Schweizer et al., 1988 . ERGIC-53 normally spends only a portion of its time in the Golgi complex as it rapidly cycles between the ER and Golgi complex (Hauri and Schweizer, 1992) . It accumulates, however, in pre-Golgi and Golgi membranes upon lowering the temperature to 16°C for several hours (Lippincott-Schwartz et al., 1990;  N.B. Cole et al. Figure 1 were analyzed for relative fluorescence intensity and distribution of Golgi fragments (see MATERIALS AND METHODS). Representative individual cell images from 0, 15, 30, 60 min and 4, 6 and 14 h are shown. The intensity profiles of these cells is qualitatively represented by applying a five-color look-up table (see upper left comer) to these images. The colors represent a spectrum of 4096 gray levels (12 bits) with 0 being the dimmest, as follows: black (0-20 arbitrary fluorescence units, a.f.u.), red (21-500 a.f.u.), green (501-1000 a.f.u.), blue (1001-2500 a.f.u.), and yellow (2501-4095 a.f.u.). The intensity profile was selected simply to illustrate that the dispersal process was not a uniform spreading out and dimming of the original Golgi signal seen at the 0-min time point. Note that at earlier times numerous dim fragments were found in the cell periphery; however, with increasing times in nocodazole, the peripheral intensity levels increased significantly, suggesting a redistribution process had occurred. Schweizer et al., 1990) due to effects of reduced temperature on membrane traffic (Saraste and Kuismanen, 1984) . Upon warmup to 37°C from 16°C, ERGIC-53 resumes cycling between the ER and Golgi, moving as a synchronous population into the ER before acquiring a steady-state distribution throughout the ER/ Golgi system (Lippincott-Schwartz et al., 1990 ). In the experiments described below we examined whether ERGIC-53 moves to the same or different sites as Galtf and how fast this redistribution occurs upon warmup from 16°C in the presence of nocodazole.
As shown in Figure 3 , ERGIC-53 appeared colocalized with Galtf in a tight juxtanuclear structure representative of the Golgi complex after 3 h at 16°C. The ultrastructural distribution of ERGIC-53 at this temperature is shown in Figure 4 . Peroxidase reaction product was localized within Golgi cisternae, as well as within surrounding vesicles, indicating that ERGIC-53 had distributed within Golgi membranes at this temperature. Strikingly, within 5 min of warmup to 37°C from 16°C (see Figure 3 ), ERGIC-53 had moved out of the central Golgi region and was localized throughout the ER, including the nuclear envelope. After 10 min at 37°C, the pattern of ERGIC-53 staining was no longer restricted to the ER but became concentrated in numerous discrete Figure 4 . Redistribution of ERGIC-53 into Golgi cistemae in cells incubated at 16'C. Ml human fibroblasts were incubated at 16'C for 3 h. The cells were then fixed, permeabilized with saponin, and labeled with anti-ERGIC-53 antibodies followed by HRP-conjugated goat anti-mouse IgG. After reaction with diaminobenzidine hydrochloride, H202, the cells were prepared for electron microscopy. HRP reaction product was found associated primarily with Golgi stacks and nearby vesicular intermediates. (A and B) Golgi regions from two different cells. Note that ERGIC-53 labeling appeared to be most enriched in the cis-most Golgi cisternae of Golgi stacks.
structures distributed throughout the cell. Accumulation of ERGIC-53 in these structures was more pronounced after 30 min at 37°C and remained associated with these peripheral structures for more than 2 h of nocodazole treatment. The distribution of Galtf was restricted to central Golgi elements at the earliest time at 37°C in nocodazole-treated cells, when ERGIC-53 had already accumulated in peripheral structures (see Figure 3 , 10 min). However, after 30 min, many of the ERGIC-53-containing fragments also contained small quantities of GalTf (Figure 3, see arrows) . By 2 h at 37°C in nocodazole, this co-localization was dramatic, with virtually every ERGIC-53-containing fragment also containing significant quantities of Galtf. Significantly, at no time during nocodazole treatment was Galtf ever observed in fragments that did not also contain ERGIC-53. Identical results were obtained in experiments where cycloheximide was included in the incubation medium. These results indicate, therefore, that itinerant (i.e., ERGIC-53) and resident (i.e., Galtf) Golgi markers redistribute at distinct rates from central Golgi structures to the same peripheral sites upon nocodazole treatment, with ERGIC-53 redistributing rapidly to these sites after first cycling through the ER, and Galtf redistributing more slowly. Additional experiments in cells whose temperature was never lowered to 16°C showed that upon nocodazole treatment, ERGIC-53 also quickly changed its distribution from a diffuse distribution including the ER and Golgi complex (see Lippincott-Schwartz et al., 1990) to discrete peripheral sites where Galtf later redistributed (our unpublished observations). Thus, whether ERGIC-53 is localized to the Golgi (i.e., at 16°C) or throughout the ER/Golgi system (at 37°C) did not affect its final distribution at 37°C in nocodazole. us to investigate further the morphology and localization of these structures. As shown by electron microscopy in Figure 5E , Golgi elements appeared as discrete mini-stacks after 2 h of nocodazole treatment and were intimately associated with regions of the ER where budding of membrane was apparent. For every set of Golgi stacks observed, budding ER membrane profiles could be seen at nearby sites. The close spatial association of peripheral, miniGolgi stacks with the ER was even more striking at the light microscopic level. As shown in Figure 6 (A and B), immunofluorescence double labeling with the cis/medial Golgi marker Man II and an ER marker in cells treated with nocodazole for 4 h showed Man II to be distributed at discrete sites adjacent to the elaborate network of ER membranes with virtually no staining in regions of the cytoplasm devoid of ER. In several places, co-distribution of red fluorescence from Man II staining and green fluorescence from ER labeling was significant enough to produce a yellow signal, indicative of an overlap in the distribution of the two markers. In contrast to Golgi markers, fluorescence staining of endosomal and lysosomal markers in nocodazoletreated cells revealed these markers to fill the spaces devoid of the ER (our unpublished observations).
Peripheral Golgi Elements Generated during
To further characterize the localization of Golgi fragments generated during nocodazole treatment, we compared the distribution of Golgi fragments with that of the temperature-sensitive viral glycoprotein, ts045 VSV G (VSV G) (Bergmann, 1989 ) upon release of this glycoprotein from the ER under conditions where transport is slowed (at 16°C or 20°C) (Griffiths et al., 1989; Saraste and Kuismanen, 1992) or limited (for 10 min at 32°C). VSV G protein is unable to fold properly and generally cannot exit the ER in cells infected with the ts045 strain of the vesicular stomatis virus that are incubated at 40°C (DeSilva et al., 1990) . Upon lowering the temperature to 32°C, however, proper folding occurs and VSV G rapidly exits the ER moving into the Golgi complex enroute to the cell surface. Infected cells were incubated for several hours in nocodazole at 40°C to accumulate VSV G in the ER while allowing Golgi enzymes to redistribute into peripheral fragments. The temperature was then lowered to 32°C for 10 min, or to 16°C or 20°C for 30 min in the continued presence of nocodazole to allow export of VSV G from the ER. Each of these conditions (see Figure 7 for 32°C for 10 min and 20°C for 30 min) resulted in the complete co-localization of VSV G in Man II-containing structures. Before Golgi fragmentation, however, a significant proportion of VSV G , 1995) , suggesting that they functioned as ER-to-Golgi trafficking intermediates (Pepperkok et al., 1993; Peter et al., 1993; Griffiths et al., 1995) , and upon removal of nocodazole redistributed into the centrosomal region (our unpublished observations). These results indicate that microtubules are necessary for the translocation into the centrosomal region of peripheral transport intermediates carrying VSV G newly released from the ER. After long periods (i.e., 30 min or more) of nocodazole treatment Man II began to appear in peripheral VSV G-containing structures (Figure 8 , see arrows) and by 2 h was completely localized with VSV G in peripheral structures. This process was analogous to the nocodazole-induced redistribution of Galtf to ER-GIC-53-containing peripheral structures illustrated in Figure 3 . Significantly, redistribution of Man II to peripheral structures containing VSV G was sensitive to temperature and did not occur in cells incubated at 20°C in nocodazole. This observation is consistent with data from Turner and Tartakoff (1989) demonstrating failure of Golgi membranes to disperse at reduced temperatures in nocodazole-treated cells.
The above results suggest that the effect of microtubule depolymerization on anterograde, ER-to-Golgi traffic varies depending on the localization of the Golgi complex. After early times of nocodazole treatment (when the Golgi is still centrosomally localized), transport of membrane from peripheral ER exit sites to the Golgi is inhibited (see Figure 8 , third panel). After Figure 8 (cont). Effect of nocodazole and reduced temperature on anterograde transport of VSV G into the Golgi complex. NRK cells infected with ts045 VSV were incubated at 40'C for 2h to accumulate VSV G in the ER. The cells were then fixed (top panel, 40'C) or placed on ice for 10 min and warmed to 32°C for 30 min in the absence of nocodazole (second panel down), to 32°C for 30 min in nocodazole (third panel down), to 32°C for 2 h in nocodazole (fourth panel down), or to 20°C for 2 h in nocodazole (bottom panel) before fixation. Cells were then permeabilized and incubated with mouse anti-VSV G antibody and rabbit anti-Man II antibody, followed by rhodamine-conjugated goat anti-mouse IgGs and fluorescein-conjugated goat anti-rabbit IgGs. Examination of the samples by fluorescence microscopy revealed that incubation in medium containing nocodazole impeded transport of peripherally distributed VSV containing structures into the centrosomal region. Upon longer treatments with nocodazole at 32°C, Man II redistributed from this centrosomal region to peripheral sites containing VSV G. Incubation with nocodazole at 20'C, however, blocked Golgi redistribution to peripheral sites. Very faint staining of VSV G could be observed on the cell surface after 2 h of chase in nocodazole at 32°C, indicating Golgi-to-surface transport occurred under these conditions. Bar, 10 ,gm.
prolonged exposure of cells to nocodazole, however, when Golgi enzymes redistribute to ER exit sites, transport is no longer blocked (see Figure 7 , second panel). This interpretation predicts that Golgi processing of newly synthesized glycoproteins should be significantly inhibited after short periods of nocodazole treatment, because peripheral pre-Golgi intermediates that transport these proteins are incapable of clustering into the centrosomal region where Golgi enzymes are concentrated. After longer periods of nocodazole treatment, however, due to redistribution of Golgi enzymes to peripheral, pre-Golgi sites, processing of these glycoproteins should occur.
To test this hypothesis, we examined the rate at which metabolically pulse-labeled VSV G proteins are converted to endo H resistance upon release from the ER in cells treated with or without nocodazole. As shown in Figure 9 , newly synthesized VSV G molecules in untreated cells were completely processed to endo H resistance within 20 to 30 min of chase at 32°C after pulse labeling. By contrast, in cells treated with nocodazole at the time of chase, the rate of processing of VSV G molecules to endo H resistance was significantly delayed and was not complete until approximately 90-120 min. This delay in processing of VSV G in nocodazole appeared to correlate to the rate of redistribution of Golgi membrane to peripheral sites (i.e., fragmentation), which occurs over 90-120 min in these cells. Consistent with this possibility, in cells pretreated in nocodazole for several hours (resulting in Golgi fragmentation) before pulse labeling, the rate of acquisition of endo H resistance of VSV G upon chase was as rapid as in untreated cells. However, in cells treated with nocodazole for 2 h at 20°C (which prevents Golgi fragmentation; see Figure 8 , bottom panel), subsequent labeling and chase at 32°C in the continued presence of nocodazole resulted in a delayed rate of processing similar to cells treated with nocodazole at 32°C at the start of the chase. These results indicate that Golgi enzyme processing of newly synthesized VSV G is inhibited at early times after microtubule depolymerization and that Golgi fragmentation appears to be necessary for the complete processing of VSV G observed at later times.
Relationship between Golgi Fragmentation and
Retrograde, Golgi-to-ER Traffic Active membrane transport has previously been implicated in the Golgi dispersal process induced by microtubule disruption (Turner and Tartakoff, 1989) . Consistent with this, we found that both Galtf and ERGIC-53 failed to redistribute to peripheral structures during nocodazole treatment and remained in central Golgi structures when the cells were exposed to the membrane traffic perturbants NEM, AIF, DOG/ azide, or monensin (see Table 1 ), in contrast to treat- Vol. 7, April 1996 Minutes in chase at 320 Figure 8 ). In contrast, under conditions where Golgi membrane is fragmented at the start of the chase (i.e., pretreatment with nocodazole at 32°C), rapid acquisition of endo H resistance by VSV G was observed. This suggests that Golgi fragmentation after microtubule disruption is required for efficient processing of newly synthesized proteins by Golgi enzymes. ment with cytochalasin D (which disassembles the actin cytoskeleton), which had no effect on the Golgi dispersal process. The observation that different molecules associated with the Golgi complex (i.e. Galtf and ERGIC-53 in human fibroblasts) redistribute at distinct rates to peripheral fragments during nocodazole treatment, and that ERGIC-53 follows a Golgi-to-ER retrograde transport pathway enroute to peripheral Golgi fragment sites during nocodazole treatment (see Figure 3) , led us to investigate whether retrograde transport played any role in Golgi dispersal. The effect of microtubule disruption on retrograde traffic of ERGIC-53, observed upon warming of cells from 16°C, and on Man II after treatment with BFA, a drug which induces exaggerated retrograde transport of Golgi proteins (Lippincott-Schwartz et al., 1990; Klausner et al., 1992) , was examined. Cells were incubated on ice for 10 min and were then warmed to 37°C (for ERGIC-53) or treatment with BFA at 37°C in the presence or absence of nocodazole (for Man II). The extent of redistribution of these molecules out of Golgi structures and into the ER was then assessed using immunofluorescence microscopy. As shown in Figure 10 , A and B, nocodazole treatment slowed, but did not block retrograde transport of both ERGIC-53 and Man II, in contrast to NEM, monensin, or DOG/azide treatments, which each significantly inhibited retrograde transport. For ERGIC-53, microtubule depolymerization increased the halftime for transport into the ER by only a few minutes, while for Man II, microtubule disruption increased the half-time of retrograde transport slightly more, from 3-5 min to 15-20 min. These combined results ( Figure  10 and Table 1) indicate that microtubules facilitate but are not required for retrograde transport and that drugs that block retrograde traffic also prevent Golgi dispersal during microtubule disruption.
To further investigate the relationship between retrograde traffic and Golgi dispersal, we treated cells with BFA to redistribute Golgi enzymes into the ER and then removed BFA in the presence of nocodazole.
As shown in Figure 5 (D and F), the fate of Golgi enzymes under these conditions was indistinguish- Figure 5 , D and F). Not only was the average number of Golgi fragments per cell under these conditions no different than in cells treated with nocodazole alone (our unpublished results), but the ultrastructure of individual fragments resembled cells treated with nocodazole alone (compare Figure  5 , E and F). These fragments consisted of stacks of short cisternae localized next to membrane budding sites of the ER ( Figure 5F , see arrow), and were functionally competent for protein secretion as determined from metabolic pulse chase experiments (our unpublished observations). These results indicate that functional Golgi stacks scattered in the cell periphery can be rapidly assembled de novo from Golgi membrane components that have followed a retrograde pathway into the ER and then been exported out again in the presence of nocodazole. The Golgi stacks remained localized to ER exit sites as long as microtubules were depolymerized, and reclustered into the centrosomal region upon microtubule repolymerization (our unpublished observations).
DISCUSSION
It has been known for years that microtubule disruption with agents like nocodazole have dramatic effects on Golgi morphology, with hundreds of functional Golgi units now appearing throughout the cytoplasm (Pavelka and Ellinger, 1983; Thyberg and Moskalewski, 1985; Turner and Tartakoff, 1989) . How this profound redistribution of Golgi membrane occurs without disrupting secretory flow from the ER is unknown. The most common thinking is that Golgi fragments generated during microtubule depolymerization arise from random diffusion within the cytoplasm of Golgi ministacks no longer tethered to microtubules. In this paper, we have drawn upon a wide variety of techniques and approaches to evaluate different models of Golgi fragmentation during nocodazole treatment and demonstrate convincingly that this is not the case. Our results reveal that after microtubule disruption the Golgi complex rebuilds itself into hundreds of ministacks in the cell periph- (Figure 10 cont.) labeled with mouse anti-Man II followed by rhodamine-conjugated goat anti-mouse IgGs. For Remarkably, Golgi fragments generated during nocodazole treatment were found to reside adjacent to ER exit sites. Multiple approaches were taken to support this conclusion, including electron microscopy, fluorescence co-localization of Golgi markers with ER markers, co-localization of Golgi markers with VSV G released from the ER at 16°C and 20°C, and co-localization of Golgi markers with ERGIC-53. Ultrastructural examination of the fragments revealed many to consist of mini-stacks. That Golgiderived components were capable of building these stacks de novo upon export out of the ER was supported in experiments where ER-retained Golgi enzymes in BFA-treated cells were released from the ER during BFA washout in the presence of nocodazole. The number, distribution, and morphology of peripheral Golgi structures formed after this treatment were indistinguishable from that of Golgi structures generated during nocodazole treatment alone. These collective data, therefore, provide powerful support for some type of Golgi assembly process occurring within the cell periphery during nocodazole treatment. Central Golgi stacks do not simply break apart and diffuse to peripheral sites.
The above results underscore the highly dynamic nature of the Golgi complex revealed from studies with agents and conditions that cause it to disassemble and reassemble (including BFA, okadaic acid, IQ, and overexpression of ELP1 or mutant Rab la) (Lippincott-Schwartz et al., 1990; Lucocq et al., 1991; Hsu et al., 1992; Takizawa et al., 1993; Wilson et al., 1994) and from studies examining the distribution of Golgi enzymes during mitosis . It is of considerable interest, therefore, that the number of Golgi fragments that we report during nocodazole treatment (on average 250 per HeLa cell) is the same number Warren and colleagues found during mitosis in HeLa cells using quantitative electron microscopy (Lucocq et al., 1989) . Although this similarity may be a coincidence, the fact that many mitotic Golgi clusters were found located next to vesicle budding sites of the ER (Lucocq et al., 1989) , suggests an underlying similarity in the process by which Golgi membrane redistributes to peripheral sites during nocodazole treatment and during mitosis.
Given a model for Golgi dispersal during microtubule disruption involving reassembly of Golgi elements at peripheral ER exit sites, how might Golgi membrane components redistribute to these sites? At least two distinct pathways can be envisioned. One involves cytoplasmic diffusion of budded Golgi vesicles to "stacking templates" or "Golgi-organizing centers," which have dispersed during microtubule depolymerization (Turner and Tartakoff, 1989) . Alternatively, Golgi membrane enroute to peripheral sites could move through existing membrane structures, like the ER (Saraste and Svensson, 1991; Saraste and Kuismanen, 1992) , which extend peripherally throughout the cytoplasm even during nocodazole treatment (Terasaki, 1986) . Both of these models are consistent with previous observations on Golgi fragmentation after microtubule disruption, which found that fragmentation is sensitive to energy depletion and membrane traffic perturbants (Turner and Tartakoff, 1991;  Table 1 ), and that rudimentary Golgi formations appear at peripheral sites before central Golgi structures are affected (Busson-Mabillot et al., 1982; Pavelka and Ellinger, 1983) . Our observations that ERGIC-53 moves through the ER before accumulating in peripheral fragments during nocodazole treatment ( Figure  3) , and that Golgi reassembly at peripheral ER sites during nocodazole treatment occurs whether Golgi enzymes are redistributed from centrosomal stacks or from the ER (during BFA washout), however, favor the latter of these models. This led us to investigate the effect of microtubule disruption on the membrane transport pathways connecting the ER and Golgi complex and its potential role in Golgi fragmentation. Figure 11 . Model for Golgi dispersal during microtubule depolymerization. In untreated cells, Golgi resident proteins would slowly flux through the same ER/Golgi membrane cycling pathways followed by rapidly cycling molecules like ERGIC-53. These molecules follow a retrograde pathway into the ER where they diffuse throughout the network of ER membranes before retuming to the Golgi complex along the anterograde pathway. Because retrograde traffic is only slightly inhibited by microtubule disruption, while anterograde transport of peripheral pre-Golgi intermediates into the centrosomal region is blocked, ERGIC-53, as well as Golgi enzymes, would accumulate at ER exit sites upon microtubule disruption. Regeneration of Golgi stacks over time in these peripheral sites would reestablish secretory flow from the ER to the Golgi and result in "Golgi fragmentation." the ER (Brands et al., 1985; Persson et al., 1992) . Nevertheless, it is possible that Golgi enzymes spend only short periods of time passing through the ER, and therefore are difficult to detect there.
In summary, our collective data all point to a model of Golgi fragmentation where recycling Golgi membranes accumulate at peripheral ER exit sites as a consequence of the inability of membranes at these sites to cluster into the centrosomal region in the absence of microtubules. De novo formation of small Golgi stacks at these peripheral sites would reestablish secretory flow from the ER into the Golgi complex and result in the Golgi dispersal phenomenon. This explanation of Golgi dispersal during microtuble disruption predicts unexpectedly heavy retrograde traffic of Golgi enzymes to ER exit sites. It has important implications, therefore, for our understanding of Golgi membrane dynamics and its relationship to microtubule-faciliated ER/Golgi membrane transport pathways.
